Literature DB >> 20535011

Benzodiazepine-associated atrioventricular block.

Anna M Arroyo Plasencia1, Lynn M Ballentine, James B Mowry, Louise W Kao.   

Abstract

Dysrhythmias, although common in overdose situations, are not often seen after benzodiazepine exposures. We report two cases of transient atrioventricular block after benzodiazepine misuse. Case 1 is a 4-year-old boy who was found unresponsive after an ingestion of clonazepam. An electrocardiogram (EKG) performed on emergency department presentation demonstrated first-degree atrioventricular block (PR 206 ms). After flumazenil administration, he developed second-degree atrioventricular block (Mobitz Type 1). EKG abnormalities resolved by morning. Serum clonazepam was 478 ng/mL (laboratory clonazepam reference range, 10-75 ng/mL with a dose of up to 6 mg/day) 5 hours after being found unresponsive. Case 2 is a 23-year-old man who presented to the emergency department after ingesting risperidone, combination hydrocodone/acetaminophen, and alprazolam. On arrival, his EKG demonstrated sinus bradycardia with a PR interval of 182 msec. He subsequently developed second-degree atrioventricular block (Mobitz Type I). Sinus bradycardia with resolution of his atrioventricular block (PR 200 ms) was seen on a third EKG performed 5 hours after presentation. These two patients demonstrated transient first- and second-degree atrioventricular block after benzodiazepine exposure. Benzodiazepines have been shown to alter L-type Ca2+ channel function. This alteration in function may account for the dysrhythmias seen in our patients. Together, these cases serve to remind clinicians of this rare but potentially serious complication associated with benzodiazepine exposure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 20535011     DOI: 10.1097/MJT.0b013e3181dcf572

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  9 in total

1.  Mobitz type 1 second-degree atrioventricular block by triazolam and brotizolam overdose.

Authors:  Masaki Hisamura; Hirokazu Taguchi; Atsushi Hiraide
Journal:  Acute Med Surg       Date:  2015-04-27

2.  Third-degree atrioventricular block in an adolescent following acute alcohol intoxication.

Authors:  Anne N H van Cleef; Marijn J Schuurman; Jamiu O Busari
Journal:  BMJ Case Rep       Date:  2011-10-04

3.  The designer benzodiazepine, flubromazepam, induces reward-enhancing and cardiotoxic effects in rodents.

Authors:  Eunchong Hong; Sun Mi Gu; Jin Mook Kim; Kyung Sik Yoon; Jin-Moo Lee; Young-Hoon Kim; Soo Kyung Suh; Dohyun Lee; Heejong Eom; Jaesuk Yun; Hye Jin Cha
Journal:  Toxicol Res (Camb)       Date:  2022-07-08       Impact factor: 2.680

4.  Benzodiazepine overdose associated atrioventricular block.

Authors:  Krithika Anand; Mritunjay Kumar
Journal:  Anesth Essays Res       Date:  2013 Sep-Dec

5.  Takotsubo Cardiomyopathy Precipitated by Tapering of Anxiolytic Medication: A Case Report.

Authors:  Christopher J Lafferty; Kristen M Lafferty; Tariq Bhat; Peter C Olson; Adam Atoot; Farshid Daneshvar; Donald A McCord
Journal:  Clin Med Insights Cardiol       Date:  2017-12-10

6.  Clonazepam-associated Bradycardia in a Disabled Elderly Woman with Multiple Complications.

Authors:  Hidetomo Maruyoshi; Natsue Maruyoshi; Motone Hirosue; Komei Ikeda; Masaaki Shimamoto
Journal:  Intern Med       Date:  2017-08-10       Impact factor: 1.271

7.  Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System.

Authors:  Matthew S Duprey; Nada S Al-Qadheeb; Nick O'Donnell; Keith B Hoffman; Jonathan Weinstock; Christopher Madias; Mo Dimbil; John W Devlin
Journal:  Drugs Real World Outcomes       Date:  2019-09

Review 8.  Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research.

Authors:  Jaden Brandt; Christine Leong
Journal:  Drugs R D       Date:  2017-12

9.  Cardiac phenotype in ATP1A3-related syndromes: A multicenter cohort study.

Authors:  Simona Balestrini; Mohamad A Mikati; Reyes Álvarez-García-Rovés; Michael Carboni; Arsen S Hunanyan; Bassil Kherallah; Melissa McLean; Lyndsey Prange; Elisa De Grandis; Alessandra Gagliardi; Livia Pisciotta; Michela Stagnaro; Edvige Veneselli; Jaume Campistol; Carmen Fons; Leticia Pias-Peleteiro; Allison Brashear; Charlotte Miller; Raquel Samões; Vesna Brankovic; Quasar S Padiath; Ana Potic; Jacek Pilch; Aikaterini Vezyroglou; Ann M E Bye; Andrew M Davis; Monique M Ryan; Christopher Semsarian; Georgina Hollingsworth; Ingrid E Scheffer; Tiziana Granata; Nardo Nardocci; Francesca Ragona; Alexis Arzimanoglou; Eleni Panagiotakaki; Inês Carrilho; Claudio Zucca; Jan Novy; Karolina Dzieżyc; Marek Parowicz; Maria Mazurkiewicz-Bełdzińska; Sarah Weckhuysen; Roser Pons; Sergiu Groppa; Daniel S Sinden; Geoffrey S Pitt; Andrew Tinker; Michael Ashworth; Zuzanna Michalak; Maria Thom; J Helen Cross; Rosaria Vavassori; Juan P Kaski; Sanjay M Sisodiya
Journal:  Neurology       Date:  2020-09-10       Impact factor: 11.800

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.